SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-010914
Filing Date
2019-04-05
Accepted
2019-04-05 16:05:29
Documents
6
Period of Report
2019-05-09
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A phas-def14a_20190509.htm DEF 14A 862684
2 GRAPHIC gcljvbpwhzuc000001.jpg GRAPHIC 3002
3 GRAPHIC gcljvbpwhzuc000005.jpg GRAPHIC 38569
4 GRAPHIC gcljvbpwhzuc000004.jpg GRAPHIC 49273
5 GRAPHIC gcljvbpwhzuc000002.jpg GRAPHIC 1627
6 GRAPHIC gcljvbpwhzuc000003.jpg GRAPHIC 1627
  Complete submission text file 0001564590-19-010914.txt   994307
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38697 | Film No.: 19735158
SIC: 2834 Pharmaceutical Preparations